Stay updated on Favipiravir Clinical Trial: Influenza Efficacy & Safety
Sign up to get notified when there's something new on the Favipiravir Clinical Trial: Influenza Efficacy & Safety page.

Latest updates to the Favipiravir Clinical Trial: Influenza Efficacy & Safety page
- ChecktodayNo Change Detected
- Check7 days agoNo Change Detected
- Check15 days agoChange DetectedMajor update: announces a version upgrade to v3.2.0 and publicly states funding-related operational notices, including that transactions may not be processed until appropriations are enacted.SummaryDifference3%
- Check22 days agoChange DetectedAppended version label (v3.1.0) and removal of multiple drug-safety related sections, indicating content consolidation and reorganization rather than new substantive content.SummaryDifference0.3%
- Check36 days agoChange DetectedAdded Revision: v3.0.2 and removed Revision: v3.0.1 along with Back to Top; overall, a minor update with no core-content changes.SummaryDifference0.2%
- Check43 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. Additionally, a 'Back to Top' feature has been added for improved navigation.SummaryDifference0.2%
- Check50 days agoChange DetectedThe webpage has been updated to include a significant number of new locations across various countries, including detailed addresses, while also removing some previously listed locations. Additionally, the study's total number of locations has increased from 222 to 225.SummaryDifference30%
- Check65 days agoChange DetectedThe web page has been updated from version 2.16.11 to version 2.16.12.SummaryDifference0.1%
Stay in the know with updates to Favipiravir Clinical Trial: Influenza Efficacy & Safety
Enter your email address, and we'll notify you when there's something new on the Favipiravir Clinical Trial: Influenza Efficacy & Safety page.